Compounds > n-propionylprocainamide
Page last updated: 2024-09-03

n-propionylprocainamide and 5-nitro-2-(3-phenylpropylamino)benzoic acid

n-propionylprocainamide has been researched along with 5-nitro-2-(3-phenylpropylamino)benzoic acid in 2 studies

Compound Research Comparison

Studies
(n-propionylprocainamide)		Trials
(n-propionylprocainamide)		Recent Studies (post-2010)
(n-propionylprocainamide)		Studies
(5-nitro-2-(3-phenylpropylamino)benzoic acid)		Trials
(5-nitro-2-(3-phenylpropylamino)benzoic acid)		Recent Studies (post-2010) (5-nitro-2-(3-phenylpropylamino)benzoic acid)
1209561090

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Book, M; Hahn, M; Luedi, MM; Rieder, HU; Stamer, UM; Stüber, F1
Chen, W; Fang, Y; Guo, N; Guo, Q; Lv, J; Wang, Z; Zeng, S; Zhao, Z1

Other Studies

2 other study(ies) available for n-propionylprocainamide and 5-nitro-2-(3-phenylpropylamino)benzoic acid

ArticleYear
ASA Status,
    Cells, 2022, 02-22, Volume: 11, Issue:5

    Topics: Atrial Natriuretic Factor; Coronary Artery Disease; Haplotypes; Humans; Natriuretic Peptide, Brain; Natriuretic Peptides; Nitrobenzoates; Peptide Fragments; Procainamide

2022
Dose-dependent Effects of PRC2 and HDAC Inhibitors on Cardiomyocyte Hypertrophy Induced by Phenylephrine.
    Current drug targets, 2023, Volume: 24, Issue:4

    Topics: Animals; Cardiomegaly; Histone Deacetylase Inhibitors; Histones; Myocytes, Cardiac; Natriuretic Peptides; Phenylephrine; Rats

2023